Exec Chat: OIC Expects To Disrupt Orthopedic Surgery Market With High Value Implants

25 Feb 2022

Itai Nemovicher, the co-founder and CEO of The Orthopedic Implant Company talked to Medtech Insight about his company’s approach to bringing high value orthopedic implants to the market and proving they can reduce the cost of surgery without diminishing patient outcomes.

Ortho surgery products from OIC — OIC's tibial nail, external fixation and distal radius plate • Source: OIC

The Orthopedic Implant Company (OIC) believes orthopedic implant devices are usually overpriced, creating an opportunity for innovative companies to reduce the costs of surgery to the health care system without compromising quality.

For the last 12 years, Reno-based OIC has been developing “high value” orthopedic implants for trauma and sports medicine that...